Nutrição e doença cardiovascular – 2ª parte

Autores

  • José Cardoso Assistente de Medicina Interna Consultas de Diabetes, Hipertensão e Dislipidemias; Mestrado em Nutrição Clínica, Faculdade de Medicina, Universidade de Lisboa; Serviço de Medicina do Hospital de Santa Marta, Lisboa

Palavras-chave:

abordagem nutricional, dislipidemias, hipertensão arterial

Resumo

O autor descreve de forma mais detalhada a
abordagem nutricional das dislipidemias e da
hipertensão arterial. Quanto à primeira questão, aspectos como o papel dos ácidos gordos,
a relação entre o colesterol alimentar e o colesterol plasmático, o papel dos vegetais, frutos e
do amido e as indicações para a utilização de
suplementos vitamínicos são referidos. Quanto
à segunda, aspectos como a redução do excesso
de peso e do sal, a utilização de suplementos de
potássio, cálcio e magnésio, os macronutrientes,
a cafeína, o álcool e o papel da actividade física são expostos.

Downloads

Não há dados estatísticos.

Referências

Katan MB et al. N Eng J Med 1997; 337: 563-566.

Grundy SM. Am J Clin Nutr 1997; 66 (4 suppl): 988S-990S.

Howard BV and Kritchevsky D. Phytochemicals and Cardiovascular Disease. Circulation 1997; 95: 2591-2593.

Key TJ et al. Br Med J 1996; 331: 775-779.

Krauss RM et al. Dietary guidelines for Healthy American Adults. Circulation 1996; 94: 1795-1800.

Denke M. Cholesterol-lowering diets. A review of evidence. Arch Intern Med 1995; 155: 17-26.

Dreon DM and Krauss RM. Molecular genetics of coronary heart disease and stroke. Basel: Karger, 1992; 35-42.

Keys A et al. Metabolism 1965; 14: 776-787.

Peres E. Aterosclerose e Dislipidemia. Prática Alimentar na Prevenção e no Tratamento. Revista Portuguesa de Cardiologia 2000; 19 (Supl

TCV-I): 43-50.

Peres E. Saber comer para melhor viver. 4ª edição revista, 2000.

Constant. J Clin Cardiol 1997; 20: 420-424.

Kromhout D. JAMA 1998; 279: 65.

Gotto AM. N Eng J Med 1991; 324: 912-913.

Kern F Jr. N Eng J Med 1991; 324: 896-899.

National Cholesterol Education Program. Circulation 1994; 89:1329-1445.

Recommendations of the Second Task Force of European and other Societies on Coronary Prevention. Prevention of coronary heart disease in clinical practice. European Heart Journal 1998; 19: 1434-1503.

Ascherio A and Willet WC. Am J Clin Nutr 1997; 66 (suppl): 1006S/1010S.

Diaz NM et al. N Eng J Med 1997; 337: 408-416.

Plotnik GD et al. JAMA 1997; 278: 1682-1686.

Boushey CJ et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefi ts of increasing

folic acid intakes. JAMA 1995; 274: 1049-1057.

Kaplan NM. Clinical Hypertension. Seventh edition. 1998.

Stamler et al. Findings of the Hypertension Detection and Follow-up Program. Hypertension 1991; 17: 553-564.

Intersalt Co-operative Research Group 1988 Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24-hour urinary sodium and potassium excretion. British Medical Journal 297: 319-328.

Robertson JIS. The modern treatment of hypertension. Journal of Human Hypertension 2000; 14 (suppl 1): S51-S52.

Graudal NA et al. Effects of sodium restriction on blood pressure, renin, aldosteron, cathecolamines, cholesterol, and tryglicerides: a

meta-analysis. JAMA 1998; 279: 1383-1391.

Young DB et al. Potassium’s cardiovascular protective mechanisms. Am J Physiol 1995; 268: R825-R837.

Allender PS et al. Dietary calcium and blood pressure: a meta-analysis of randomised clinical trials. Ann Intern Med 1996; 124: S25-S31.

Gilbert D’Angelo EK et al. Magnesium relaxes arterial smooth muscle by decreasing intracellular calcium without changing intracellular

magnesium. J Clin Invest 1992; 89: 1988-1994.

Delva PT et al. Intralymphocyte free magnesium in a group of subjects with essential hypertension. Hypertension 1996; 28: 433-439.

Paolisso G et al. Chronic magnesium administration enhances oxidative glucose metabolism in thiazide treated patients. Am J Hypertension 1992; 5: 681-686.

He J et al. Dietary fi ber supplementation and blood pressure reduction: a meta-analysis of controlled clinical trials. Am J Hypertension 1996; 9: 74A.

Appel LJ et al. A clinical trial of the effects of dietary patterns on blood pressure. N Eng J Med 1997; 336: 1117-1124.

Appel LJ et al. Does supplementation of diet with “fi sh oil” reduce blood pressure? Arch Intern Med 1993; 153: 1429-1438.

Stamler et al. Inverse relation of dietary protein markers with blood pressure. Findings for 10200 men and women in the Intersalt Study.

Circulation 1996; 94: 1629-1634.

Renaud et al. Alcohol and platelet aggregation: the Caerphilly prospective heart disease study. Am J Clin Nutr 1992; 55: 1012-1017.

Hendriks HFJ et al. Effects of moderate dose of alcohol with evening meal on fi brinolytic factors. Br Med J 1994; 308: 1003-1004.

Report of a Joint Working Group of the Royal Colleges of Physicians, Psychiatrists and General Practioners. Alcohol and heart in prespective. Royal College of Physicians of London 1995.

Peres E e Moreira P. Alimentação de adolescentes e prevenção de doenças cardiovasculares. Endocrinologia, Metabolismo e Nutrição

; 2: 267-273

Ficheiros Adicionais

Publicado

30-09-2004

Como Citar

1.
Cardoso J. Nutrição e doença cardiovascular – 2ª parte. RPMI [Internet]. 30 de Setembro de 2004 [citado 11 de Outubro de 2024];11(3):123-31. Disponível em: https://revista.spmi.pt/index.php/rpmi/article/view/1754

Edição

Secção

Artigos Originais